Larry L. Wood - 05 Mar 2026 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Reporting relationship: President, CEO, Director
Issuer ticker: PRCT
Reported as of: 05 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Mar 2026, 17:45:06 UTC
Prior SEC filing: 04 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Stone, as Attorney-in-Fact for Larry Wood

Key filing fact

Larry L. Wood filed Form 4 for PROCEPT BioRobotics Corp (PRCT) on 09 Mar 2026.

Key facts

This page summarizes Larry L. Wood's Form 4 filing for PROCEPT BioRobotics Corp (PRCT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Mar 2026, 17:45.

Change

Previous filing in this sequence was filed on 04 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001440660 Primary reporting owner

Wood Larry L

Relationship: President, CEO, Director
Address: C/O PROCEPT BIOROBOTICS CORPORATION, 150 BAYTECH DRIVE, SAN JOSE
Signature: /s/ Jonathan Stone, as Attorney-in-Fact for Larry Wood
Signature date: 09 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRCT transaction

Common Stock

Award

Transaction value
Shares: +127,783
Change %: +69%
Price: $0.000000^*
Shares after: 313,378
Date: 05 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRCT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +103,653
Change %
Price: $0.000000^*
Shares after: 103,653
Date: 05 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 103,653
Exercise price: $25.35
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.

Footnote F2

1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.